It is a prime concern of Evotec that all relevant target groups receive the same information at the same time. This implies communicating in both English and German.

Please find below the most recent corporate news, ad hoc releases and other announcements of our Company.

 

2017

Evotec to Acquire Aptuit, Expanding Leadership in External Innovation
Nerina Coppini, 30 July 2017

We are pleased to share the press release published today about the agreement between Evotec AG and Aptuit under which Evotec will acquire Aptuit.

2016

Aptuit announces acquisition of Kuecept Ltd
Jim Regan, 10 May 2016

Expanding capabilities in formulation development to include specialist pre-formulation, formulation prototyping and formulation development services Greenwich, CT, May, 10th, 2016 - Aptuit, LLC today announced that it has acquired Kuecept Ltd to meet strong customer demand for specialist drug pre-formulation, formulation prototyping and...

Aptuit announces acquisition of Exquiron Biotech AG
Jim Regan, 21 April 2016

Expands Capabilities in Discovery to Include High Throughput Screening and Other Early Discovery Services Greenwich, CT, April 21st, 2016 - Aptuit, LLC today announced that it has acquired Exquiron Biotech AG to meet customer demand for fully integrated outsourced discovery services. Exquiron is a leading specialist Contract Research...

 

Other announcements

Merger

The following annoucement has been published in the German Federal Gazette in accordance with the German Conversion Act (Umwandlungsgesetz) in 2013. Pursuant to the German Conversion Act, certain transaction intended by Evotec AG, e.g. up-stream mergers, have to be announced in the Federal Gazette (Bundesanzeiger).

Contact us

Gabriele Hansen

VP, Corporate Communications & Investor Relations

T +49 40 560 81 255 F +49 40 560 81 333 vCard

Katja Werner

Investor Relations Associate

T +49 40 560 81 210 F +49 40 560 81 333 vCard